Buscar

Referencias

  1. Adams, E.K.; Miller, V.P.; Ernst, C.; Nishimura, B.K.; Melvin, C.; y Merritt, R. Neonatal health care costs related to smoking during pregnancy. Health Economics 11:193–206, 2002.
  2. Belluzzi, J.D.; Wang, R.; y Leslie, F.M. Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats. Neuropsychopharmacol 30:705–712, 2005.
  3. Benowitz, N.L. Pharmacology of nicotine: Addiction and therapeutics. Ann Rev Pharmacol Toxicol 36:597–613, 1996.
  4. Breslau, N., y Johnson, E.O. Predicting smoking cessation and major depression in nicotine-dependent smokers. Am J Public Health 90(7):1122–1127, 2000.
  5. Buka, S.L.; Shenassa, E.D.; y Niaura, R. Elevated risk of tobacco dependence among offspring of mothers who smoked during pregnancy: A 30-year prospective study. Am J Psychiatry 160:1978–1984, 2003.
  6. Covey, L.S.; Glassman, A.H.; y Stetner, F. Major depression following smoking cessation. Am J Psychiatry 154:263–265, 1997.
  7. Dervaux, A., y Laqueille, X. Smoking and schizophrenia: Epidemiological and clinical features. Encephale 34(3):299–305, 2008.
  8. Ernst, M.; Moolchan, E.T.; y Robinson, M.L. Behavioral and neural consequences of prenatal exposure to nicotine. J Am Acad Child Adolesc Psychiatry 40:630–641, 2001.
  9. Fowler, J.S.; Volkow, N.D.; Wang, G.J.; Pappas, N.; Logan, J.; MacGregor, R.; Alexoff, D.; Shea, C.; Schlyer, D.; Wolf, A.P.; Warner, D.; Zezulkova, I.; y Cilento, R. Inhibition of monoamine oxidase B in the brains of smokers. Nature 22:733–736, 1996.
  10. Hatsukami, D.K.; Lemmonds, C.; Zhang, Y.; Murphy, S.E.; Le, C.; Carmella, S.G.; y Hecht, S.S. Evaluation of carcinogen exposure in people who used “reduced exposure” tobacco products. J Natl Cancer Inst 96:844–852, 2004.
  11. Henningfield, J.E. Nicotine medications for smoking cessation. New Engl J Med 333:1196–1203, 1995.
  12. Ilomäki, R., y cols. Temporal association of onset of daily smoking with adolescent substance use and psychiatric morbidity. Eur Psychiatry 23(2):85–91, 2008.
  13. John, U.; Meyer, C.; Rumpf, H.J.; y Hapke, U. Smoking, nicotine dependence and psychiatric comorbidity: A populationbased study including smoking cessation after three years. Drug Alcohol Depend 76:287–295, 2004.
  14. Johnston, L.D.; O’Malley, P.M.; Bachman, J.G.; y Schulenberg, J.E. Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2008. NIH Pub. No. 09-7401. Bethesda, MD: National Institute on Drug Abuse, 2009. Disponible en: www.monitoringthefuture.org.
  15. Kalman, D.; Morissette, S.B.; y George, T.P. Comorbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict 14(2):106–123, 2005.
  16. Kollins, S.H.; McClernon, F.J.; y Fuemmeler, B.F. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a populationbased sample of young adults. Arch Gen Psychiatry 62:1142–1147, 2005.
  17. Levin, E.D.; Rezvani, A.H.; Montoya, D.; Rose, J.E.; y Swartzwelder, H.S. Adolescent-onset nicotine self–administration modeled in female rats. Psychopharmacol 169:141–149, 2003.
  18. Morissette, S.B.; Tull, M.T.; Gulliver, S.B.; Kamholz, B.W.; y Zimering, R.T. Anxiety, anxiety disorders, tobacco use, and nicotine: A critical review of interrelationships. Psychol Bull 133(2):245–272, 2007.
  19. Perkins, K.A.; Donny, E.; y Caggiula, A.R. Sex differences in nicotine effects and self–administration: Review of human and animal evidence. Nic and Tobacco Res 1:301–315, 1999.
  20. Saccone, S.F., y cols. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 16(1):36–49, 2007.
  21. Substance Abuse and Mental Health Services Administration. Results from the 2008 National Survey on Drug Use and Health: National Findings. DHHS Pub. No. SMA 09-4434. Rockville, MD: Office of Applied Studies, 2009. Disponible en: http://oas.samhsa.gov/nsduh/2k8nsduh/2k8Results.cfm.
  22. Thorgeirsson, T.E., y cols. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452(7187):638–642, 2008.
  23. U.S. Department of Health and Human Services. Reducing Tobacco Use: A Report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2000. Disponible en: http://www.cdc.gov/tobacco/data_statistics/sgr/index.htm.
  24. U.S. Department of Health and Human Services. The Health Benefits of Smoking Cessation: A Report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1990. Disponible en: http://www.cdc.gov/tobacco/data_statistics/sgr/index.htm.
  25. U.S. Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004. Disponible en: http://www.cdc.gov/tobacco/data_statistics/sgr/2004/index.htm.
  26. Upadhyaya, H.P.; Deas, D.; Brady, K.T.; y Kruesi, M. Cigarette smoking and psychiatric comorbidity in children and adolescents. J Am Acad Child Adolesc Psychiatry 41(11):1294–1305, 2002.

Página actualizada en marzo del 2010

Herramientas